Xtl Biopharmaceuticals (XTLB) Asset Writedowns and Impairment (2014)
Xtl Biopharmaceuticals (XTLB) recorded Asset Writedowns and Impairment of $223,000 in the year ended Dec 31, 2025.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Asset Writedowns and Impairment (2014) Analysis & Trends
Starting with the year ended Dec 31, 2013, Xtl Biopharmaceuticals' Asset Writedowns and Impairment history includes 5 years.
- The figure for the year ended Dec 31, 2025 is the highest annual Asset Writedowns and Impairment since the year ended Dec 31, 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Xtl Biopharmaceuticals | 2.03 Bn | 2.03 Bn | - |
API Access
Xtl Biopharmaceuticals Asset Writedowns and Impairment API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-writedowns-and-impairment", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();